Press release
Which Key Regions Hold Lion’s Share in Helicobacter Pylori Non-Invasive Testing Market?| Present and Future analysis till end of 2026 by Fact.MR
Helicobacter Pylori infections, or H. Pylori, are the most common types of infections affecting the digestive tract. The infection is prevalent among half of the world’s population, who typically reside in unhygienic and poor sanitary conditions. It is the most common reason for dyspepsia, peptic ulcers and gastric adenocarcinoma.Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/4774/helicobacter-pylori-hpylori-noninvasive-testing-market
In view of this, the demand for H. Pylori testing has increased, particularly non-invasive molecular techniques such as real-time PCR and Chemiluminescence Immunoassay (CLIA). The Helicobacter Pylori Non-Invasive Testing market is anticipated to register a moderate CAGR of 3.9% during the forecast period (2020-2026).
Key Takeaways of Global H. Pylori Non-Invasive Testing Market Study:
• By test type, the urea breath test segment is anticipated to hold a major chunk of the market, amounting to over two-fifth. High rate of accuracy in detecting the presence of H. Pylori and usefulness in evaluating post-treatment status are poised to leverage this segment.
For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4774
• The Stool Antigen Test segment shall comprise the 2nd largest share of the global H. Pylori Non-invasive testing market, accounting for over 40%. Simplicity and accuracy of the test in determining infection is anticipated to drive the segment’s growth.
• By test method, the Laboratory-based Tests segment shall generate high demand. The ability to test a large number of patients and their accurate and precise methodologies are anticipated to be the key drivers. The segment is foreseen to hold more than three-fifth of the market.
• By end-use, diagnostic labs are anticipated to be the most lucrative, capturing almost half of the total market. Key pharmaceutical companies partnering to provide wider reach for testing H. Pylori are anticipated to drive the market. For instance, in 2010, Meridian Bioscience entered into an agreement with DiaSorin S.p.A to develop infectious disease tests for use on its LIAISON automated instrumets.
For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=4774
• North America is anticipated to be the most promising market. This is attributed to changing healthcare reforms. These reforms have directed organizations to abandon serology tests due to its uncertainty in predicting infections and to switch to urea-based and stool antigen testing. The region is anticipated to hold 31.1% of the H. Pylori testing market.
• Asia-Pacific shows modest growth opportunities, owing to increased awareness about H. Pylori infections and government efforts to contain the risk of infections. Moreover, H. Pylori testing among communities with gastric cancer has increased, preventing further risks. The region is anticipated to expand modestly at a CAGR of 4.5%.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4774
“The global helicobacter pylori non-invasive testing market shows modest future growth prospects. The increasing prevalence of h. pylori associated diseases have prompted manufactures to invent non-invasive testing and treatment methods to reduce the incidence of such diseases,” concludes a Fact.MR analyst.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/04/04/1797163/0/en/Operating-Room-Equipment-Demand-Upheld-by-Increasing-Investments-to-Upgrade-Surgical-Rooms-in-Hospitals.html
Global Helicobacter Pylori (H. Pylori) Non-invasive testing: Market Segmentation
Fact.MR has studied the global helicobacter pylori (h. pylori) Non-invasive testing market with detailed segmentation on the basis of Non-invasive Test Type, Test Method, End-user and key regions.
Non-invasive Test Type
• Serology Test
• Stool Antigen Test
• Urea Breath Test
Test Type
• Laboratory-based Tests
• Point-of-Care Tests
End-user
• Hospitals
• Diagnostic Labs
• Clinics
Key Regions
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)
Global Helicobacter Pylori Non-Invasive Testing Market: Competitive Landscape:
The global H. Pylori non-invasive testing market comprises of the following market players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=4774
Meridian Bioscience, Inc. markets its tests and assay kits to hospitals, reference laboratories and other diagnostic manufacturers in more than 60 countries. Its H. Pylori testing products include the Premium Platinum HpSA PLUS or Premium H. Pylori. It is an in vitro qualitative procedure to detect the presence of H. Pylori bacteria in the human stool.
Exalenz Biosciences manufactures the H. Pylori IgG ELISA Kit, BreathID HP, BreathID Smart and Breath ID Lab devices. These devices conduct a quick and accurate Urea Breath Test for diagnosing H. Pylori infection and confirming post-treatment eradication. The test is conducted in real-time by continuously sampling breath, eliminating the need for sample collection, labeling, transport and analysis.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1538/global-helicobacter-pylori-hpylori-noninvasive-testing-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Which Key Regions Hold Lion’s Share in Helicobacter Pylori Non-Invasive Testing Market?| Present and Future analysis till end of 2026 by Fact.MR here
News-ID: 2301971 • Views: …
More Releases from Fact.MR
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between…
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032.
Market Drivers & Outlook
The demand for…
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems.
Key…
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate…
More Releases for Pylori
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Is Booming So Rapidl …
HTF MI just released the Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Abbott Laboratories,…
Helicobacter pylori (H. pylori) Infections Market is expected to reach $9.1 bill …
Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that colonizes the stomach lining, causing chronic gastritis, peptic ulcers, and significantly increasing the risk of gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. It affects nearly half of the global population, though prevalence varies by geography, socioeconomic conditions, and sanitation levels.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71739
Management of H. pylori infections typically relies on antibiotic-based eradication therapies, combined…
Helicobacter pylori H. pylori Diagnostics Market Is Set to Experience Revolution …
The Helicobacter pylori (H. pylori) diagnostics Market was valued at USD 554.46 million in 2021. It is expected to increase from USD 587.68 million in 2022 to USD 953.25 million by 2030, with a compound annual growth rate (CAGR) of 6.01% during the forecast period of 2023-2030.The popularity of H. pylori diagnostics is growing due to its benefits in improving diagnosis, enabling effective treatment, and reducing healthcare costs.
Detecting H. pylori…
Helicobacter Pylori (H Pylori) Non-Invasive Testing Market Share, Size, Demand, …
Helicobacter Pylori (H Pylori) Non-Invasive Testing Market size was valued at over USD 447 million in 2022. Driven by the increasing instances of peptic ulcers, the market is slated to register over 6.5% CAGR from 2023 to 2032. The Helicobacter Pylori (H. Pylori) Non-invasive Testing market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Helicobacter Pylori (H. Pylori) Non-invasive Testing market.…
Helicobacter pylori (H. pylori) Diagnostics Market to Witness Exponential Growth …
Helicobacter pylori (H. pylori) is a spiral shaped gram-negative aerobic bacterium commonly found in the stomach. Bacteria plays a vital role in balancing stomach ecology. When H. pylori invades and attacks the stomach lining, it causes stomach infections. These infections are commonly found in both men as well as women. Nearly 30% of the world's population is infected by H. pylori. In some countries, the bacteria infects more than 50%…
Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market : Latest Innovations, …
The global helicobacter pylori (H. pylori) non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, “Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”, published by Transparency Market Research (TMR) . The report suggests…